Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.130
+0.040 (1.91%)
Oct 27, 2026, 4:10 PM AEDT
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 793.4 million as of October 27, 2026. It is the 13,845th most valuable company in the world and the 258th biggest in Australia. Its market cap has decreased by 18.13% in one year.
Market Cap
793.40M
Enterprise Value
1.34B
Revenue
788.62M
Global Rank
Country Rank
#258 Australia
PE Ratio
36.72
ChartMarket Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 793.40M, an increase of 200.79%. That is a compound annual growth rate of 10.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 793.40M | -16.19% |
| Dec 31, 2025 | 946.69M | -12.49% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.43B |
| Australian Clinical Labs | 551.44M |
| Healius | 319.51M |
| Monash IVF Group | 276.64M |
| Identifai Genetics | 74.87M |
| Cryosite | 59.55M |
| BCAL Diagnostics | 29.49M |
| Microba Life Sciences | 25.21M |